Accessibility

Labcorp and its Specialty Testing Group, a fully integrated portfolio of specialty and esoteric testing laboratories.

Vitamin K1

CPT: 84597

Synonyms

  • Phylloquinone
  • Phytonadione

Expected Turnaround Time

4 - 6 days


Related Documents


Specimen Requirements


Specimen

Serum or plasma, frozen and protected from light


Volume

1.5 mL


Minimum Volume

1 mL


Container

Lavender-top (EDTA) tube, red-top tube without anticoagulant, or amber plastic transport tube with amber top. (If amber tubes are unavailable, cover standard transport tube completely, top and bottom, with aluminum foil. Identify specimen with patient's name directly on the container and on the outside of the aluminum foil. Secure with tape.) For amber plastic transport tube and amber-top, order LabCorp N° 23598.


Collection

Draw blood in chilled lavender-top tubes containing EDTA or in chilled red-top tubes with no anticoagulant. Gently invert five to six times to mix if using anticoagulant tube. Keep unopened vacuum tube on ice before processing. Immediately separate plasma/serum from red cells using refrigerated centrifugation or prechilled centrifuge carrier tubes before centrifuging. Serum or plasma must be separated from cells within 45 minutes of venipuncture. Transfer serum or plasma specimen to a labeled amber transport tube and freeze on dry ice. Protect from light. To avoid delays in turnaround time when requesting multiple tests on frozen samples, please submit separate frozen specimens for each test requested.


Storage Instructions

Freeze serum or plasma on dry ice in plastic amber transport tube with amber top. Not stable refrigerated. Protect from light. Stable for three months at -20°C.


Causes for Rejection

Specimen not protected from light; specimen not received frozen; use of anticoagulants other than EDTA has not been studied


Test Details


Use

Vitamin K deficiency may be induced by obstructive liver disease, obstructive icterus, malabsorption due to celiac disease, pancreatitis, diarrhea, and antibiotic abuse; may be used to treat blood clotting disorders, bone metabolism disorders, and hemorrhagic disorders of newborns.


Limitations

This test was developed and its performance characteristics determined by LabCorp. It has not been cleared or approved by the Food and Drug Administration.


Methodology

High-pressure liquid chromatography (HPLC) with electrochemical (EC) detection


Reference Interval

• 0 to 1 year: 0.13−3.37 ng/mL

• 2 to 17 years: 0.13−1.39 ng/mL

• >17 years: 0.13−1.88 ng/mL


Additional Information

In humans, deficiency of vitamin K leads to decreased concentrations of circulating, active coagulation factors, which often results in bleeding. Vitamin K nutritional status has also been implicated in osteoporosis. Interest in vitamin K has increased beyond its well-established function in blood clotting with human epidemiological and intervention studies suggesting that vitamin K may reduce bone loss in osteoporotic people and decrease fracture risk.


For Providers

Please login to order a test

Order a Test

© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf